Price $0.41 |
Market Cap
13.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
18.93
|
P/S
6.44
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-200
|
FCF
-
|
|
Op. Margin
-114.60%
|
Net Margin
-94.20%
|
ROE
-285.80%
|
ROI
-134.00%
|
|
ROA
-60.00%
|
EPS Growth
56.40%
|
Current Ratio
0.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| American Bio Medica Corporatio (ABMC) | $0.05 | - | - | 2.5M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $4.93 | - | - | 1.59B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $68.15 | - | 2.90% | 148.62B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $26.50 | - | - | 1.04B | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.13 | - | - | 60.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
